Bronx, NY, United States of America

Ekaterina Doubrovina

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • West Orange, NJ (US) (2018 - 2020)
  • Bronx, NY (US) (2019 - 2021)

Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ekaterina Doubrovina: Innovator in Cellular Therapy

Introduction

Ekaterina Doubrovina is a prominent inventor based in the Bronx, NY (US). She has made significant contributions to the field of cellular therapy, particularly in the treatment of cancer and viral infections. With a total of 6 patents to her name, her work has the potential to impact many lives.

Latest Patents

Doubrovina's latest patents include innovative methods for selecting T cell lines and donors for adoptive cellular therapy. These methods are designed to select an allogeneic T cell line for therapeutic administration to patients who have or are suspected of having a pathogen or cancer. Additionally, she has developed methods for treating CMV (cytomegalovirus) retinitis in patients, particularly those infected with HIV or who have received solid organ transplants.

Career Highlights

Throughout her career, Ekaterina has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Cornell University. Her research has focused on advancing the understanding and application of T cell therapies, which are crucial in the fight against various diseases.

Collaborations

Doubrovina has collaborated with notable colleagues in her field, including Richard John O'Reilly and Susan Elizabeth Prockop. These partnerships have further enhanced her research and contributions to cellular therapy.

Conclusion

Ekaterina Doubrovina stands out as an influential inventor in the realm of cellular therapy, with her innovative patents paving the way for new treatment options. Her dedication to advancing medical science continues to inspire and benefit many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…